The QualityStocks Daily Friday, July 27th, 2018

Today's Top 3 StockMarketWatch

TopPennyStockMovers (AWX) +80.14%

BUYINS.NET (BSPM) +35.09%

StocksToBuyNow (BRVVF) +23.60%

The QualityStocks Daily Stock List

Ecosphere Technologies, Inc. (ESPH)

TheMicrocapNews, PennyStocks24, Buzz Stocks, Penny Pick Finders, PennyStockProphet, SmallCapVoice, Wall Street Resources, Planet Penny Stocks, SecretStockPromo, and StockOnion reported earlier on Ecosphere Technologies, Inc. (ESPH), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Ecosphere Technologies, Inc. is a development and Intellectual Property (IP) licensing company. It develops environmental solutions for global water, energy, industrial, and agricultural markets. The Company helps industry increase production, lessen costs, and protect the environment through a portfolio of inventive, patented technologies and exclusive and nonexclusive licensing opportunities across a wide spectrum of industries and applications globally. Ecosphere Technologies is based in Stuart, Florida.

Ecosphere has a wide-ranging portfolio of patented clean technologies. These can be purchased and licensed for use in large-scale and sustainable applications across industries, nations, and ecosystems. The Company’s technologies include the Ecos PowerCube®, the Ecos GrowCube™, and Ozonix®.

The Ecosphere technologies and products are available via many brands and subsidiaries. These include Sea of Green Systems, Ecosphere Development Company, and Fidelity National Environmental Solutions. The Company’s goal is to help clean energy producers’ gain more control over their water resources, quality, and completion costs through providing effective mobile water recycling solutions.

The Ecosphere Ozonix® Technology provides a chemical-free alternative to high-volume water recycling for a varied range of applications. These range from the oil & natural gas industry and mining to agriculture and municipal wastewater treatment. The oil and natural gas industry is successfully using Ecosphere Technologies’ patented Ozonix® technology to treat and recycle the water used in oil and natural gas well drilling and completion programs.

The Ecos PowerCube® is the world’s largest, mobile, solar-powered generator. It runs on high power photovoltaic panels. These panels extend from its container combined with an easy to set up wind turbine. Energy is stored in onboard batteries.  

The Ecos GrowCube® is a state-of-the-art, turn-key, fully-automated "greenhouse". It uses hydroponic growing techniques to maximize the amount of crop production possible in a given footprint. The Ecos GrowCube® incorporates Ecosphere’s patented Ozonix® water treatment technology. In addition, Ecosphere has its Ozonix Sentinel. This is the world's first line of water treatment vessels for cleaning up endangered rivers and lakes.

Sea of Green Systems (SOGS), a subsidiary of Ecosphere Technologies, announced in January 2017 the launch of its SOGS-650X, Full Spectrum LED Growing Light. This light was developed to provide growers with an engineered solution to maximize vegetative growth and flower production for the indoor agriculture and legal marijuana industries.

The SOGS-650X can produce greenhouse-like conditions through providing an average 25 DLI (Daily Light Integral) during the Vegetative and Flowering Cycles, with about 450-650 uMols and 700-900 uMols at the plant canopy during their respective growth cycles. Sea of Green Systems (SOGS) sells high-tech growing equipment, lighting solutions, and nutrients to the Precision Agriculture industry.

Yesterday, Sea of Green Systems announced that its sublicensee in the agricultural industry, Gulf Coast Organics (GCO), signed an agreement with Wedgworth's, Inc., to be the exclusive distributor in Florida for its Amp Agronomy™ plant nutritional line. Wedgworth's is recognized as Florida's largest custom fertilizer dealer since 1932. Wedgworth's provides custom blended agricultural plant nutrient products across Florida to help farms grow and prosper. CAVISONIX®, developed by SOGS and Ecosphere Technologies, utilizes ultrasonic cavitation to treat fertilizers for increased plant availability.

Ecosphere Technologies, Inc. (ESPH), closed Friday's trading session at $0.01, up 5.82%, on 198,016 volume with 7 trades. The average volume for the last 60 days is 71,760 and the stock's 52-week low/high is $0.004/$0.033.

chart

Viking Energy Group, Inc. (VKIN)

FatCat Stocks, SmallCapFinancialWire, Daily Stock Motion, Penny Pick Insider, Penny Stocks VIP, Wall Street Beauties, WINNINGOTC, SMS Penny Picks, Greenbackers, and Undiscovered Equities reported on Viking Energy Group, Inc. (VKIN), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Viking Energy Group, Inc. is an independent exploration and production corporation. The Company targets under-valued assets with realistic appreciation potential. Viking Energy owns oil and gas leases in Kansas, Missouri, Texas, Louisiana, Mississippi and Alberta. Fundamentally, Viking Energy purchases interests in producing, long-life, low-cost oil properties producing positive cash-flow. It is not considering speculative exploration programs.

The Company is headquartered in New York, New York. Viking Energy Group lists on the OTCQB. The Company formerly went by the name Viking Investments Group, Inc. It changed its name to Viking Energy Group, Inc. in March 2017.

The Company focuses on acquiring under-valued, producing properties from distressed vendors or those considered as non-core assets by larger sector participants. Viking Energy targets properties with current production and untapped reserves for future benefit.

In Missouri, the Company owns a 100 percent W1 (about NRI 83 percent) in 31 leases, with access to the mineral rights (oil and gas) regarding roughly 5,500 acres of property in Cass and Bates Counties.

In the Province of Alberta, Viking Energy has a Joint Venture (JV) with Tanager Energy, Inc. Its investment with Tanager Energy includes a 50 percent WI in the Joffre Project, consisting of 4 oil wells and one water injection well. Tanager Energy’s initial project incorporates the Leduc D-3 B Pinnacle Reef in Central Alberta where the Joffre D-3 Oil Project is located (the Joffre Project).

Viking Energy has acquired additional working interests in a variety of oil and gas-related leases in Eastern Kansas. On September 11, 2017, Viking, through a wholly-owned subsidiary, Mid-Con Drilling, LLC, acquired a 90 percent WI in four new oil and gas leases in Anderson County in Eastern Kansas, consisting of approximately 980 acres of property.

Viking Energy, through its wholly-owned subsidiary, Mid-Con Petroleum, LLC, owns a working interest in 7 producing oil leases with access to the mineral rights (oil and gas) concerning approximately 800 acres of property in Miami and Franklin Counties in Eastern Kansas. Its working interests (WI’s) in the leases range from 68 percent to 100 percent.

Viking Energy Group announced in January 2018 that it acquired, through its wholly-owned subsidiary, Mid-Con Development, a majority WI in several oil leases in Ellis and Rooks Counties in Kansas. Features of the acquired assets include greater than 40 oil leases, comprising approximately 3,300 acres.

At the end of April, Viking Energy Group announced a Net Comprehensive Income for the year ended December 31, 2017 of roughly $17.8 million, coupled with an increase in the value of its oil and gas properties of about $36.2 million over the previous year, as outlined in its Annual Report on form 10-K/A for the 2017 calendar year.

The considerable increase in asset value is credited to the six acquisitions completed by Viking from September 2017 through December 31, 2017. This includes a bargain purchase gain of about $27 million relative to the Company’s strategic acquisition of Petrodome Energy, LLC on December 22, 2017, and its acquisition of the above-mentioned 40 new oil leases in Kansas on December 29, 2017.

Viking Energy Group, Inc. (VKIN), closed Friday's trading session at $0.19, up 8.51%, on 17,980 volume with 5 trades. The average volume for the last 60 days is 55,358 and the stock's 52-week low/high is $0.09/$0.34.

chart

Aphria, Inc. (APHQF)

Stock Twits, Profit Confidential, Midas Letter, CFN Media Group, Finance Registrar, and Cannabis Financial Network News reported earlier on Aphria, Inc. (APHQF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Aphria, Inc. is one of Canada’s lowest cost producers that produces, supplies, and sells medical cannabis. Its medical cannabis products are 100 percent greenhouse grown. The Company works to provide pharmaceutical-grade medical cannabis and premier patient care. Its dedication is to do this while balancing patient economics and returns to shareholders. OTCQB-listed, Aphria has its corporate office in Leamington, Ontario.

Aphria is a Health Canada Licensed Producer of medical cannabis products. The Company’s cannabis oil products are produced employing C02 extraction methods. These methods preserve purity and ensure safety. Aphria’s equivalency factor of cannabis oil to dried cannabis is 6:1. As a result, every 6 mL of cannabis oil is equivalent to 1 gram of dried cannabis.

Aphria is in the middle of a multi-phase expansion program. Upon completion of Part II, the Company expects that annual production capacity will reach 5,500 kilograms of dried cannabis and 9,000 liters of cannabis oil.

Aphria will rename its earlier-acquired subsidiary Nuuvera as Aphria International, remaining as a wholly-owned subsidiary of Aphria. Aphria International will focus its activities on established regulated cannabis markets around the world. This includes where Aphria International already has major interests.

Currently, these markets include Europe, Africa and the Middle East, with assets and agreements in Germany, Italy, Spain, Portugal, Malta, Lesotho, and others. Also, Aphria's existing assets and interests in Australia will be managed under Aphria International.

This month, Aphria announced its planned expansion into Latin America and the Caribbean with the proposed acquisition of industry-leading companies in Colombia , Argentina , Jamaica as well as a right of first offer and refusal regarding Brazil via a definitive share purchase agreement with Scythian Biosciences, Inc. Aphria will acquire 100 percent of the issued and outstanding common shares of LATAM Holdings, Inc., which is a direct, wholly-owned subsidiary of Scythian Biosciences.

Yesterday, Aphria announced that it completed its largest global shipment of cannabis oil so far to Australian medical life science company, Medlab Clinical Limited. This shipment is part of the earlier announced agreement between Aphria and Medlab in which Aphria produces and supplies high-yield cannabis extracts for Medlab Clinical to be used in a human trial to test the management of intractable pain in oncology patients. This is the first trial of its kind worldwide.

Aphria, Inc. (APHQF), closed Friday's trading session at $8.50, up 6.25%, on 561,305 volume with 1,652 trades. The average volume for the last 60 days is 784,445 and the stock's 52-week low/high is $4.46/$19.869.

chart

DOCASA, Inc. (DCSA)

Barchart, MarketWatch, and Iconstockalerts reported on DOCASA, Inc. (DCSA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

DOCASA, Inc. focuses on investing in the fast-growing specialty coffee market, chiefly in the United Kingdom (UK). The Company, via its subsidiary, Department of Coffee and Social Affairs Ltd. (London, England) has established and is building an award-winning, market leading UK specialty coffee shop and online retail business. Department of Coffee and Social Affairs served its first coffee in December 2010 at Leather Lane, London.

DOCASA has its corporate headquarters in Schaumburg, Illinois. The Company lists on the OTC Markets Group’s OTCQB.

During the period December 2016 through February 2017, DOCASA opened four new shops in Kingston, Whitechapel, and Bank Street in London, as well as one shop in Bristol. The Company’s stores sell proprietary coffee and related products, and also complementary food and snacks.

DOCASA is also pursuing franchising and/or licensing of its branded shops and premium product offerings outside of the UK. This is in nations where the premium coffee market is fast growing.

DOCASA, by way of its award-winning subsidiary, Department of Coffee and Social Affairs Limited, previously announced the securing of its first coffee shop site in Manchester, UK. The new site is on the ground floor of Faulkner House, which is a 25,000-sq. ft. building of serviced offices, in Manchester's Piccadilly Gardens area. The new site is the Department of Coffee and Social Affairs' flagship store and barista training hub in the northern part of England.

DOCASA, through Department of Coffee and Social Affairs Limited, has secured a new coffee shop location. This is in The Arts Theatre in London's world famous West End.

DOCASA, through Department of Coffee and Social Affairs Limited, has secured a first liquor license for its newly extended and refurbished coffee shop in London's iconic Old Spitalfields Market. The Company’s coffee shops in Central London are in premium spots with foot traffic of more than 1 million people each day.

DOCASA, via Department of Coffee and Social Affairs Limited, announced in August of 2017 the launch in the United States of its award-winning specialty coffee shops, securing its first site at 800 Diversy in Chicago, Illinois.

DOCASA President & Chief Executive Officer, Ashley Lopez, said last August, "Our launch in the U.S. is a natural progression following our success and market leading position in the UK specialty coffee market. The consumption of specialty coffee is increasing as shoppers are now prioritizing experience over price in the consumption of coffee.  We are the "affordable premium product" and our particular appeal to coffee lovers is reflected in everything we do.  Chicago is a great place to launch into the U.S., being one of the top 5 cities in the U.S. where people of the "millennial" age live…”

DOCASA, Inc. (DCSA), closed Friday's trading session at $0.99, up 15.12%, on 9,699 volume with 14 trades. The average volume for the last 60 days is 17,699 and the stock's 52-week low/high is $0.41/$2.00.

chart

GulfSlope Energy, Inc. (GSPE)

OTC Markets, InvestorsHub, MarketWatch, Stockhouse, Morningstar, Equity Clock, and Financial Times reported on GulfSlope Energy, Inc. (GSPE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

GulfSlope Energy, Inc. is an independent oil and natural gas company concentrating on exploring offshore U.S. Gulf of Mexico. The Company uses 2.2 million acres of 3D seismic data to identify high quality exploration prospects. Its team has a track record of discovering and developing multi-billion-dollar projects globally, with greater than 300 years of combined experience in the oil and gas exploration industry. OTCQB-listed, GulfSlope Energy is based in Houston, Texas.

GulfSlope Energy’s portfolio has diversity in size, water depth, drilling depth, and risk profile. The Company’s target is the Shelf Miocene (2.2 MM Acres - 440 Blocks).

GulfSlope’s current emphasis is on pre-drill operations. It has a hybrid operating model with a preference to operate. The Miocene Subsalt Play – La Shelf has large resource potential; is low to moderate risk; has moderate drilling and development costs; has shortened times to initial production, and enhanced economics.

Regarding its Phase 1 Drilling Program, GulfSlope has high-graded five prospects with mean unrisked resource potential of 623 MMboe. The Company is looking to capitalize on strategic advantages provided by exploration work to identify undervalued producing assets.

GulfSlope Energy has more than 2 billion boe of net conventional recoverable resources. It has 23 lease blocks with 19 drilling prospects ranging from 30-280 MMboe. The average size of the prospects is 120 MMboe.

GulfSlope Energy and Texas South Energy, Inc. (TXSO) have entered into a strategic partnership with Delek Group Ltd., a global independent oil and gas company based in Israel. The Companies and Delek have mutually agreed to pursue oil and natural gas opportunities in the Gulf of Mexico.

Yesterday, GulfSlope Energy announced that it has the Rowan Ralph Coffman jack-up rig under tow in the Gulf of Mexico to the Vermilion Area, South Addition Block 378.  GulfSlope plans to begin drilling operations at the Canoe Prospect by August 1, 2018, pending final rig inspection and drilling approval from the Bureau of Ocean Management (BOEM).

Immediately after the drilling of the Canoe well, GulfSlope Energy will mobilize the Ralph Coffman to drill the initial exploration well on the Tau prospect on Ship Shoal Area, South Addition Blocks 336/351. 

GulfSlope Energy, Inc. (GSPE), closed Friday's trading session at $0.128, down 4.48%, on 1,113,034 volume with 86 trades. The average volume for the last 60 days is 912,349 and the stock's 52-week low/high is $0.007/$0.20.

chart

Cocrystal Pharma, Inc. (COCP)

Wall Street Resources, Microcapmillionaires, Promotion Stock Secrets, and PennyStocks Forever reported on Cocrystal Pharma, Inc. (COCP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cocrystal Pharma, Inc. develops novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The Company utilizes innovative technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The design of these technologies, including its nucleoside chemistry expertise and market-centered approach to drug discovery, are to efficiently deliver small molecule therapeutics, which are safe, effective, and convenient to administer. A biotechnology company, Cocrystal Pharma has offices in Tucker, Georgia and Bothell, Washington.

The Company’s proprietary technologies revolve around a structure-based drug discovery strategy teamed up with extensive nucleoside experience. Employing techniques called protein cocrystallization and X-ray crystallography, Cocrystal Pharma quickly identifies novel binding sites, identifies critical inhibitor-protein interactions, and optimizes the structure of the inhibitor in a highly rapid iterative fashion.

Cocrystal Pharma has identified promising, preclinical stage antiviral compounds for unmet medical needs. These include hepatitis, influenza, as well as norovirus infections. The Company is developing a series of compounds that are potent non-nucleoside and nucleoside inhibitors of hepatitis C NS5B RNA dependent RNA polymerase, a replication enzyme vital to viral replication and are highly conserved between all hepatitis C genotypes. Consequently, inhibitors of this enzyme are likely to have multi- or pan-genotypic activity.

Furthermore, Cocrystal Pharma is developing compounds that inhibit hepatitis C helicase and NS5A, two enzymes vital for viral replication. Additionally, the Company has identified a picomolar inhibitor of NS5A, another important viral replication protein. Its compounds that target NS5B hepatitis C polymerase, NS5A, and NS3 helicase will undergo development as a combination treatment.

Cocrystal Pharma previously announced the successful completion and positive data from the Phase 1a/1b study for its lead broad spectrum compound, CC-31244, in healthy volunteers and in hepatitis C virus (HCV)-infected individuals. CC-31244 is a broad-spectrum, potent NS5B non-nucleoside inhibitor (NNI) of HCV replication with a high barrier to resistance. There were no dose-limiting adverse events, study discontinuations because of adverse events, or serious adverse events reported.

Cocrystal Pharma announced in September of 2017 that it entered into a research collaboration with HitGen, Ltd., a private biotechnology company and InterX, Inc., a private computer software company, to develop small molecule drug candidates against several undisclosed targets.

Through the collaboration, Cocrystal Pharma, HitGen, and InterX scientists will apply HitGen's DNA-encoded library (DEL) technology platform and research capabilities in the design, synthesis, and screening of multiple proprietary DELs.

The DEL technology enables a large number of compounds to be quickly identified for specific drug targets. Cocrystal Pharma will utilize its industrialized crystallization and co-crystallization technology to determine at near atomic resolution the structures of HitGen's selected library compounds that interact with drug targets. Also, InterX will utilize its advanced proprietary software to design superior drugs from the information provided by Cocrystal Pharma and HitGen.

Cocrystal Pharma, Inc. (COCP), closed Friday's trading session at $4.53, up 2.26%, on 32,587 volume with 121 trades. The average volume for the last 60 days is 114,157 and the stock's 52-week low/high is $1.61/$9.00.

chart

Golden Leaf Holdings Ltd. (GLDFF)

Stockhouse, Silicon Investor, Marketwired, InvestorX, InvestorsHub, MarketWatch, and Daily Marijuana Observer reported on Golden Leaf Holdings Ltd. (GLDFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Golden Leaf Holdings Ltd. is one of the largest cannabis oil and solution providers in North America. The Company is also a foremost cannabis enterprise in Oregon. Golden Leaf has expertise in extracting, refining, marketing, and selling cannabis oil. The Company is headquartered in Toronto, Ontario.

Golden Leaf is a leading cannabis products company built around recognized brands. It has operations in numerous jurisdictions including Oregon, Nevada and Canada. The Company cultivates, extracts, manufactures and distributes its products by way of its branded Chalice Farms retail dispensaries and through third party dispensaries.

Golden Leaf’s brands include Golden, Proper, Left Coast Connection, and Chalice Farms. Since opening in 2014, Chalice Farms has served the greater Portland, Oregon community with its chain of dispensaries selling its line of 12 premium edibles.

Golden Leaf has its Canadian subsidiary, Medical Marijuana Group (MMG).  MMG's genetic portfolio includes a strain that holds the highest CBD concentrations in Canada.

MMG was granted a cultivation license from Health Canada in November of 2017 for its state-of-the-art grow facility in the Province of Ontario. It began cultivation activities in early 2018. Since then, MMG has cultivated four complementary strains of cannabis, which span some of the most desired products in the medical and adult-use market. In early July, MMG harvested its first crops that had yields that were 30 percent more than originally forecasted.

Golden Leaf has its new edible product line of cannabis infused fruit chews. Golden is a Portland-based oils and extracts brand within the Golden Leaf portfolio. The new fruit chews feature a combination of premium cannabis oil, real fruit, and restorative ingredients.

Earlier this month, Golden Leaf announced the introduction of a number of cannabis concentrate product lines in Nevada via its wholly-owned subsidiary, Greenpoint Nevada. Greenpoint’s product launch includes its Golden Tinctures; its Golden Private Stash distillate vape cartridges; and its Golden CBD product lines using Golden Leaf’s best-in-class, cold ethanol extraction processes and proprietary blends of strain-specific terpenes. 

Via its Nevada operations, Golden Leaf products are now selling in more than half of the dispensaries in the State. The expectation is that market share will increase once Golden Leaf invests further in production infrastructure.

This week, Golden Leaf Holdings announced that it received, from the Oregon Liquor Control Commission, state licensure to operate its extraction facility in Portland, Oregon, effective July 19, 2018.

Mr. William Simpson, Golden Leaf Holdings’ Chief Executive Officer, said, “This facility will allow us to continue leveraging our experienced product development team to perform advanced research and development in cannabis extraction and allow us to introduce new and exciting products into the marketplace.”

Golden Leaf Holdings Ltd. (GLDFF), closed Friday's trading session at $0.162, up 2.08%, on 741,758 volume with 159 trades. The average volume for the last 60 days is 485,311 and the stock's 52-week low/high is $0.12/$0.5805.

chart

Pharma-Bio Serv, Inc. (PBSV)

Zacks reported earlier on Pharma-Bio Serv, Inc. (PBSV), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Pharma-Bio Serv, Inc. is a compliance, project management, and technology transfer support consulting firm. Its main business is Food and Drug Administration (FDA) and other global regulatory compliance agency related services, with integrated portfolio services including microbiological and chemical testing services. This includes microbiological and chemical testing services for clients in the Pharmaceutical, Biotechnology, and Chemical, Medical Device, Cosmetic, Food and Allied Products industries, at its laboratory testing facility in Puerto Rico.

Pharma-Bio Serv has its corporate office in Dorado, Puerto Rico. In addition, the Company has operations in the United States Ireland, and Spain. Pharma-Bio Serv lists on the OTC Markets Group’s OTCQB.

The Company supports its clients through the product lifecycle. This includes research and development (R&D) Studies; NDA Documentation and Filings; PAI Readiness; Audit & Inspection Preparation, Management and Response, and Post Approval. Moreover, this includes Quality Systems; Technology Transfer; Validation, and also Manufacturing Controls & Process Support.

Pharma-Bio Serv’s services also include "Pharma Serv Academy." This division provides technical and regulatory standards seminars/training conducted by industry experts.

The Company’s divisions include Scienza Labs, the abovementioned PharmaServ Academy, and Metrologix. Scienza Labs provides microbiological and analytical testing, field support, method development, and validation. Metrologix provides laboratory and on-site calibration services, calibration program management, risk management, compliance remediation, and instrument rental.

Recently, Pharma-Bio Serv announced that Net Revenues for the year ended October 31, 2017 were $15.6 million. This represents a decrease of roughly $4 million, or 20 percent, versus last year.

The revenue decrease is primarily because of decreases in the Puerto Rico consulting market and the Puerto Rico Lab of $3.7 and $0.4 million, respectively. In addition, these results include declines of $0.2 and $0.1 million, in the Puerto Rico consulting market and the Puerto Rico Lab respectively, which are due to the impacts of Hurricanes Irma and Maria, and declines in the U.S. and Brazil consulting markets of $0.2 and $0.1 million, respectively.

Mr. Victor Sanchez, Pharma-Bio Serv’s Chief Executive Officer, said, "As of the end of fiscal year 2017, we have quickly recovered from the Hurricanes, focused our attention back to our strategies, including the US consulting services strategy, with a more streamlined business development approach, and started benefiting from incoming consulting opportunities in Europe."

Pharma-Bio Serv, Inc. (PBSV), closed Friday's trading session at $0.635, up 4.10%, on 14,179 volume with 7 trades. The average volume for the last 60 days is 11,256 and the stock's 52-week low/high is $0.325/$0.70.

chart

Applied BioSciences Corp. (APPB)

Stockhouse, InvestorsHub, Daily Marijuana Observer, Simply Wall St, TradingView, OTC Markets, Penny Stock Hub, Investors Hangout, Stockopedia, and The Stock Market Watch reported on Applied BioSciences Corp. (APPB), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Applied BioSciences Corp. is a diversified cannabinoid therapeutics company. It focuses on the medical, bioceutical and pet health industries. The Company was formerly known as Stony Hill Corp. OTCQB-listed, Applied BioSciences is based in Beverly Hills, California.

The Company’s focus is on select investment, branding, real estate, and partnership opportunities in the recreational, health and wellness, nutraceuticals and media industries. Applied BioSciences products include Remedi CBD and TherPet.

Applied BioSciences uses organic ingredients and formulations created to target common ailments in the health and wellness industry for anyone who is open to trying hemp derived products. The products use industrial hemp as an input to produce high quality CBD for an assortment of health and wellness products. Remedi CBD is a line of premium hemp-derived CBD products. These products include topicals, gummies, and more.

Applied BioSciences has expanded its product line and launched a hemp-derived CBD product line under the Remedi CBD brand. Furthermore, Applied BioSciences has started sales of its hemp-derived CBD products on LeafLink's industry-leading B2B (Business-to-Business) e-commerce platform.

Applied BioSciences’ wholly-owned animal health subsidiary, TherPet, has entered the equine health market with the launch of a new full-spectrum hemp-derived cannabidiol (CBD) supplement formulated specifically for a horse's health and wellness. TherPet's Equine Care CBD line is a natural supplement.

Last month, Applied BioSciences announced that it entered into a marketing and distribution agreement with CanaGel™ to launch their first patent-protected product, Hemp Oil Gel Melts. Applied BioSciences will be adding the patented CanaGel™ Hemp Oil Gel Melts to its wide-ranging group of product offerings.

Chris Bridges, President of Applied BioSciences, said, "Since all CanaGel™ products are non-GMO, vegan, paleo, gluten-free, and sugar-free, we knew that consumers would be interested in an exciting new alternative to the existing oils, capsules, edibles and chewables on the market."

Applied BioSciences will take advantage of its North American and European marketing and distribution channels to assist CanaGel™ in launching its first doctor-developed product.

Applied BioSciences Corp. (APPB), closed Friday's trading session at $1.75, up 11.46%, on 2,041 volume with 5 trades. The average volume for the last 60 days is 1,211 and the stock's 52-week low/high is $1.01/$3.50.

chart

Zoom Telephonics, Inc. (ZMTP)

FeedBlitz, Marketbeat.com, Wall Street Mover, OtcWizard, SmallCapVoice, and OTC Picks reported on Zoom Telephonics, Inc. (ZMTP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 1977, Zoom Telephonics, Inc. is a top manufacturer of cable modems and other communications products. The Company designs, produces, markets, and also supports cable modems and other communications products under the Zoom, Hayes®, and Global Village® brands. Zoom Telephonics is headquartered in Boston, Massachusetts and the Company lists on the OTCQB.

Zoom Telephonics’ products include cable modems & gateways, dial-up modems, mobile broadband modems and routers, wireless networking products, ADSL gateways, Bluetooth wireless products, wireless keyboards, and ZoomGuard wireless sensors & controls.

Furthermore, products include asymmetric digital subscriber line modems, wireless local area networking products, Voice Over IP products (VoIP), wired networking equipment, dialers and related telephony products, wireless sensors and controls, phone jacks and AC power adapters, and language-related specifics.

In May 2015, Zoom Telephonics signed an exclusive license agreement with Motorola Mobility LLC. The license agreement is for the Motorola brand in connection with consumer cable modem products. This includes cable modem bridges, cable modem/routers, and cable set-top boxes containing cable modems, for the U.S. and Canada. The agreement started on January 1, 2016 and runs through December 31, 2020.

In September 2017, Zoom Telephonics announced the signing of an amendment to its license agreement with Motorola Mobility to include the exclusive worldwide rights for the Motorola brand for consumer-grade cellular modems and gateways, DSL modems and gateways, and MoCA (Multimedia over Coax) adapters.

In addition, this amendment grants Zoom Telephonics non-exclusive worldwide rights to use the Motorola brand for consumer-grade cellular home sensors, which are products designed, marketed, and sold for use by consumers for their personal, family, or household use.

Last month, Zoom Telephonics announced that it started shipments of the Motorola MM1000. This is a bonded 2.0 MoCA Adapter produced under exclusive license from Motorola Mobility LLC.

The MM1000 utilizes a home's existing coaxial cables. This is to provide a high-speed wired Ethernet connection between a router's Ethernet LAN port and any device that has an Ethernet port. The MM1000 sends and receives data at up to 1,000 Mbps between a router or modem/router and an HDTV, computer, wireless access point, game station, DVD player, network storage device, TiVo box, or other Ethernet-capable device.

In January, Zoom Telephonics announced that it expects Revenue for Q4 ended December 31, 2017 to exceed $8 million. It expects to announce full Q4 and annual 2017 financial results this month.

Zoom Telephonics, Inc. (ZMTP), closed Friday's trading session at $2.89, up 3.21%, on 20,036 volume with 17 trades. The average volume for the last 60 days is 7,847 and the stock's 52-week low/high is $1.71/$4.11.

chart

iCo Therapeutics, Inc. (ICOTF)

OTC Markets Group, TheMicrocapNews, Wall St Report, and Vantage Wire reported earlier on iCo Therapeutics, Inc. (ICOTF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

iCo Therapeutics, Inc. identifies existing development stage assets for use in underserved ocular and infectious diseases. It owns the global exclusive rights to an oral delivery system - Amphotericin B (Amp B) - for life-threatening infections. Amphotericin B is the gold standard for systemic antifungal drugs. It is one example of a well-established, highly efficacious systemic antifungal drug that has a 50-year history of intravenous therapy. OTCQB-listed, iCo Therapeutics is based in Vancouver, British Columbia.

The Company centers its efforts on development instead of research. iCo’s business model aims to acquire the rights to drugs that are either off-patent, currently approved or near commercialization, and develop them through redosing or reformulating them for new or expanded labels.

iCo Therapeutics has its partnership with Immune Pharmaceuticals (IMNP), which is in a number of Phase 2 studies involving iCo-008.  iCo-008 is also known as Bertilimumab or CAT-213.

iCo-008 is a human monoclonal antibody targeting eotaxin-1, a member of the chemokine family of proteins, which acts as a messenger between the cells of the immune system. Immune Pharmaceuticals initiated a Phase 2, double-blind, placebo-controlled study with iCo-008 in 90 patients with moderate-to-severe ulcerative colitis.

iCo continued to advance its Oral Amphotericin B Delivery System (Oral Amp B) in 2016. It undertook pre-clinical pharmacokinetic and distribution studies using its optimized formulations. The Company stated that data from these studies support the further development of its Oral Amp B with once a day dosing possible in certain indications.

Amphotericin B is a well-known approved drug for the treatment of fungal and parasitic infections. iCo is developing a proprietary oral reformulation of Amphotericin B.

iCo Therapeutics, and its subsidiary iCo Therapeutics Australia Pty Ltd., announced in November of 2017 that it was granted ethics approval in Australia to conduct its proposed Phase 1 clinical study for Oral Amphotericin B.

This month, iCo Therapeutics, and its subsidiary iCo Therapeutics Australia Pty Ltd., announced a positive pharmacokinetic secondary end point in its Phase 1 clinical study. iCo earlier reported that the study met its primary endpoint of safety and tolerability of iCo-019 (Oral Amp B) following oral administration of single ascending doses (4 dose levels) in healthy subjects. This includes no gastrointestinal events of note. At present, the Company expects to present and publish detailed results in a peer reviewed publication once all intellectual property (IP) filings have been secured.

The Phase 1 Australian study conducted was a randomized, double-masked, placebo-controlled, single dose ascending study to evaluate the safety, tolerability, and bioavailability of iCo-019 (Oral Amphotericin B) in healthy male and non-pregnant female subjects between 18-55 years of age.

iCo Therapeutics, Inc. (ICOTF), closed Friday's trading session at $0.08666, down 0.32%, on 3,187 volume with 2 trades. The average volume for the last 60 days is 54,714 and the stock's 52-week low/high is $0.02/$0.2035.

chart

Summer Energy Holdings, Inc. (SUME)

Penny Stock Tweets, Capital Cube, Zacks, Street Insider, Investors Hub, and MarketWatch reported on Summer Energy Holdings, Inc. (SUME), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Summer Energy Holdings, Inc. operates as a retail electric service provider in Texas. The Company has its wholly-owned subsidiaries - Summer Energy, LLC, a Texas Limited Liability Company (Summer LLC), Summer Energy of Ohio, LLC (Summer Ohio), and Summer EM Marketing (Marketing LLC). Summer Energy Holdings has its corporate office in Houston, Texas. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Summer Energy’s sole operations are conducted through Summer LLC. Summer Energy acquires wholesale energy and resells to commercial and residential customers.

The Summer LLC subsidiary is a licensed Retail Electricity Provider (REP) in Texas. Typically, Texas regulatory structure allows REPs, such as Summer LLC, to obtain and sell electricity at unregulated prices. REPs pay the local transmission and distribution utilities a regulated tariff rate for delivering electricity to its customers.

As an REP, Summer Energy sells electricity and provides the related billing, customer service, collections and remittance services to commercial and residential customers.

The Company’s geographic coverage includes Dallas/Fort Worth Metroplex, Houston and the Greater Houston area, Corpus Christi, and all surrounding cities. Summer Energy’s focus is on delivering reliable, low cost solutions to customers throughout Texas.

Residential customers are a secondary target market. Summer Energy anticipates that most of its customers will be in the Houston and Dallas-Fort Worth metropolitan areas. Nonetheless, the Company anticipates a groing number will be in a variety of other metropolitan and rural areas within Texas.

The principal target in the commercial market is small to medium-sized customers (less than one megawatt of peak usage). However, Summer will selectively pursue larger commercial customers by way of Management's existing, historical relationships.

Summer Northeast, a Texas limited liability company previously named REP Energy, LLC, was acquired on November 1, 2017. It became a wholly-owned subsidiary of Summer Energy Holdings. Summer Northeast is a retail electric provider. It serves electric load to commercial and residential customers in the Northeastern United States. It holds licenses in Massachusetts, New Hampshire, Connecticut, and Rhode Island.

Summer Energy Holdings, Inc. (SUME), closed Friday's trading session at $2.44, even for the day. The average volume for the last 60 days is 459 and the stock's 52-week low/high is $1.40/$5.00.

chart

Rego Payment Architectures, Inc. (RPMT)

InvestorsHub.com, Investing.com, and MarketWatch reported on Rego Payment Architectures, Inc. (RPMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Rego Payment Architectures, Inc. previously operated under the name Virtual Piggy, Inc. On March 16, 2017, the Company, creators of the only COPPA compliant technology targeted at providing payment capability for the under 18 market, announced its name change to reflect the progression of the Company into broader payment-related markets.

REGO Payment Architectures, Inc. became an umbrella under which the Intellectual Property (IP) developed becomes available to many varied industries beyond the under 18 market. OTCQB-listed, Rego Payment Architectures is based in Palm Beach, Florida.

The Company’s core technology base is established on validated artificial intelligence (AI) techniques. It has wide-ranging capability to adapt to a broad array of payment markets and users. The core technology consists of ReTRO (Real Time Regulatory Oversight), established on advanced AI techniques, a system of reasoning engines, and a Contract Model (CM) that permits the creation of specific boundary conditions for its use.

Additionally, the Company has its NOMad (Networks of Meaning ad-vantage). This is an advanced data mining application, which monitors people and the things they interact with. Also, Rego has its RSM (REGO Payment Architectures, Secure Financial Messaging) - the payment control system.

REGO Payment Architectures signed a definitive agreement with Be Informed BV, effective July 2017, for the Company’s commercial launch of its inventive digital mobile payment system. The terms and conditions allow Rego's COPPA compliant OINK payment platform unlimited use of its developed technology to be available to children and their families for direct mobile payments.

Rego Payment Architectures and Be Informed have also entered into three new MOU’s in expectation of the many and various expanding markets where this mobile payment technology will be advantageous. The MOU's allow Rego to enter into production agreements under similar terms and conditions to its OINK payment platform. The agreements cover the expected welfare benefits, the unbanked, and closed loop platforms.

REGO Payment Architectures recently announced that it demonstrated the Beta version of the OINK Payment System for Children. OINK (Online Instant Networking Keypad) is a technology that speeds up payments and makes making payments simple and streamlined. This Beta release is a significant milestone for the Company. It sets the stage for the general release in September 2017 when it will be tested by 400 students of diverse demographic backgrounds in four independent schools. Rego is presently in the process of security testing to ensure that the system has all the protection it needs for transaction processing and data integrity.

Last month, Rego Payment Architectures announced the appointment of Mr. David Knight as its Chief Operating Officer (COO) and President. Mr. Knight is an experienced industry executive. He has almost thirty years of experience working for Fortune 500 companies. These include eBay, PayPal, Quaker Oats, PepsiCo, Gatorade, and Frito Lay.

Rego Payment Architectures, Inc. (RPMT), closed Friday's trading session at $0.2725, up 9.02%, on 5,041 volume with 4 trades. The average volume for the last 60 days is 50,808 and the stock's 52-week low/high is $0.10/$0.44.

chart

The QualityStocks Company Corner

Cannabis Strategic Ventures, Inc. (OTC: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures, Inc. (OTC: NUGS) (the "Company") is pleased to announce the completion of the financial audits for fiscal years 2016 and 2017. The Company is now in the process of preparing full financial reports and completing its financial audit for the year ended March 31, 2018, in preparation for moving NUGS to fully reporting status with the Security and Exchange Commission (SEC).

Cannabis Strategic Ventures, Inc. (OTC: NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $2.15, up 1.90%, on 10,286 volume with 29 trades. The average volume for the last 60 days is 34,896 and the stock's 52-week low/high is $0.031/$7.13.

Recent News

chart

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF)

The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF).

Building on its industry-leading technology and proven results, ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) is proud to the announce the introduction of FIRESIDE, its first recreational cannabis brand.

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” ABcann Global CEO Barry Fishman said.

ABcann Global owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

ABcann has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by ABcann’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting ABcann’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

ABcann’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with ABcann’s philosophy of quality and innovation.

ABcann’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, ABcann also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

ABcann Global (ABCCF), closed the day's trading session at $0.848, up 5.08%, on 266,179 volume with 210 trades. The average volume for the last 60 days is 217,297 and the stock's 52-week low/high is $0.65/$3.2929.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) patented DehydraTECH™ drug delivery platform has already received some eight patents granted and nearly 50 pending worldwide, and the company has applied for one more to the USPTO. This is because, in lab studies, the proprietary technology has shown evidence of transporting active pharmaceutical ingredients (APIs) across the brain’s protective blood brain barrier, the company announced in an article published by the CFN Media Group (http://cnw.fm/Ze5gE).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.58, up 3.27%, on 67,362 volume with 111 trades. The average volume for the last 60 days is 241,431 and the stock's 52-week low/high is $0.322/$2.54.

Recent News

chart

Pacific Software, Inc. (OTC: PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software Inc. (OTC:PFSF), a developer, distributor and master licensor of Hyperledger blockchain-based technology solutions, announces it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

Pacific Software, Inc. (OTC: PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture, cannabis, and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

Agriculture
For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Cannabis
Perceiving blockchain as an ideal mechanism for the complexities of the cannabis industry, Pacific Software will strive to improve the transparency, compliance, and efficiency of the “seed-to-sale” supply chain in states where the plant is legal.

Controlled Substances
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $4.00, even for the day. The average volume for the last 60 days is 49 and the stock's 52-week low/high is $4.00/$4.00.

Recent News

chart

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF)

The QualityStocks Daily Newsletter would like to spotlight Marifil Mines Ltd. (MFMLF).

Junior exploration company Marifil Mines (TSX.V: MFM) (OTCQB: MFMLF) is primarily focusing on Argentinean mineral resource acquisitions. To view the full article, visit: http://nnw.fm/rKl42.

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF), headquartered in Vancouver, Canada, is engaged in the exploration, evaluation and acquisition of mineral rich resource properties in Argentina. A rising global demand for cobalt and lithium is generating interest in Marifil Mines and its resources located within South America’s famed “Lithium Triangle,” which include 15,267 hectares spanning its recently acquired Ratones and Fraile claims, as well as two lithium properties covering the southern portions of the Carachi Pampa salar in the Argentine province of Catamarca.

The company’s property also includes the Las Aguilas nickel-copper-cobalt deposit property, with more than four contiguous claims in the San Luis province of Argentina. The Las Aguilas property, which is 100% owned by Marifil, is noted as one of the largest cobalt properties in Argentina. Other noteworthy properties in the company’s portfolio include the Toruel copper-silver property, with more than two contiguous claims, and additional potash properties in Punta Colorada, Pedernal and El Carmen.

Marifil’s sizable portfolio of cobalt and lithium claims in what is recognized as the world’s most prolific mining jurisdiction for these resources strategically positions the company to benefit as global initiatives push demand for lithium-ion batteries toward a frenzy. Zion Market Research, a leading research and consulting firm, has forecast that the lithium-ion battery market could hit $67 billion by 2022, realizing a CAGR of more than 13.7% from 2017-2022. Both lithium and cobalt are major components of these energy storage solutions, with industry data indicating that the battery industry currently consumes roughly 42 percent of global cobalt production.

The company is reviving a lithium exploration program that was active in Argentina a decade ago, building on an unexplored mine it owns there. Marifil will utilize a large proprietary geologic and geochemical data base it developed during its 2009 lithium exploration program in the Salta and Catamarca province sites to resume lithium exploration in the region.

Applications for a second mine and negotiations to purchase a third property are underway, which would establish a significant property portfolio of ‘salar’ brine evaporation lakes. Hydrothermal solutions emanating from regional faults in area volcanoes often enrich the brine with lithium, boron, potassium and magnesium.

In addition to nearly 152,000 acres of lithium-staked properties, Marifil owns 887 acres of land for cobalt exploration and 91,565 acres of gold mining rights in an advanced exploration stage in San Roque that company engineers indicate has high gold discovery potential with “excellent infrastructure and mining friendly politics.”

To date, more than $7.5 million has been invested assessing Marifil’s flagship San Roque gold property, including nearly 16,000 meters of diamond core drilling. The property is jointly owned by Marifil and Novagold Resources, with Marifil holding a 51% stake and serving as the current project operator. The company recently commenced a drilling campaign to further evaluate several deposits of significant gold-silver-indium-lead-zinc mineralization on a 4-kilometer-long zone.

Marifil has closed a private placement funding for $2 million that will inject additional life into the company. Proceeds from the funding will benefit acquisition plans, the ongoing drilling program at Marifil’s gold claim and other output from its general working capital accounts.

Robert Abenante, a chartered professional account, serves as president and chief executive officer of the company. He has extensive experience in the public markets and has served as an officer and director of several public and private companies across various industries, with particular success in the mining sector.

Marifil Mines Ltd. (MFMLF), closed the day's trading session at $0.096, even for the day. The average volume for the last 60 days is 1,910 and the stock's 52-week low/high is $0.01/$0.165.

Recent News

chart

SinglePoint, Inc. (OTCQB: SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (OTCQB: SING) was a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program discussing “money and what makes it happen.” To view the full interview, visit: http://nnw.fm/y9iCk. To view the full press release, visit: http://nnw.fm/46kjA.

SinglePoint, Inc. (OTCQB: SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.03832, off by 0.47%, on 2,342,233 volume with 148 trades. The average volume for the last 60 days is 7,127,469 and the stock's 52-week low/high is $0.0219/$0.415.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

NetworkNewsAudio announces the Audio Press Release (APR) titled "Self-Driving and Electric Vehicles Are Combining to Make the Cars of the Future" featuring Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX). To hear the NetworkNewsAudio version, visit: http://nnw.fm/pS8nP. To read the original editorial, visit: http://nnw.fm/0hKlM.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $3.011, off by 1.28%, on 4,859 volume with 24 trades. The average volume for the last 60 days is 59,048 and the stock's 52-week low/high is $2.44/$8.20.

Recent News

chart

NUGL Inc. (OTC: NUGL)

The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

NUGL Inc. (OTC: NUGL), the cannabis industry’s new standard of technology, this morning announced the eagerly anticipated launch of its brand locator and profile claiming features for the cannabis community and its rapidly growing fan base. To view the full press release, visit: http://cnw.fm/Od2dk.

NUGL Inc. (OTC: NUGL), is a search engine and online directory for the marijuana industry. NUGL’s database includes listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands. The company focuses on leading the evolution in business relations, development and organic data in the cannabis industry with metasearch technology.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $1.50, off by 2.60%, on 175,652 volume with 179 trades. The average volume for the last 60 days is 116,258 and the stock's 52-week low/high is $0.405/$1.80.

Recent News

chart

DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

DPW Holdings, Inc. (NYSE American: DPW) Highlighted by WallStEquities.com as they revisit the Diversified Electronics industry, which comprises companies that design, develop, and market a variety of electronics components used not just in electronics products, such as computers, cell phones, and tablets, but also in construction, such as lighting fixtures.

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.5111, off by 2.52%, on 2,873,977 volume with 3,640 trades. The average volume for the last 60 days is 2,097,399 and the stock's 52-week low/high is $0.4911/$5.95.

Recent News

chart

Marijuana Company of America Inc. (OTC: MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

CannabisNewsAudio announces the Audio Press Release (APR) titled "Proposed Legal Changes Offer a Boost for Cannabidiol Companies in the United States," featuring Marijuana Company of America Inc. (OTC: MCOA). To hear the CannabisNewsAudio version, visit http://cnw.fm/5axXg. To read the original editorial, visit http://cnw.fm/hW1EQ.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.028495, off by 3.44%, on 4,866,947 volume with 230 trades. The average volume for the last 60 days is 7,937,244 and the stock's 52-week low/high is $0.022/$0.0728.

Recent News

chart

ChineseInvestors.com (OTCQB: CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

Premier financial information company ChineseInvestors.com, Inc. (OTCQB: CIIX) provides education and analysis concerning innovative transnational currency opportunities. To view the full article, visit: http://ccw.fm/Cv9Gz. Also today, NetworkNewsWire released a report on the company detailing how CIIX’s CEO Warren Wang said in a recent SmallCapVoice interview that he expects to expand CIIX’s previously announced ATM network to eventually include the Canadian cities of Vancouver and Toronto. Focusing on international growth, he also announced that the company will offer its Bitcoin Trading Academy online courses in Asia to reach a larger audience (http://nnw.fm/7su9k).

Founded in 1999, ChineseInvestors.com (OTCQB: CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.385, off by 1.28%, on 11,779 volume with 10 trades. The average volume for the last 60 days is 59,743 and the stock's 52-week low/high is $0.365/$1.58.

Recent News

chart

Medical Cannabis Payment Solutions (OTC: REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Cannabis-focused financial services company Medical Cannabis Payment Solutions (OTC: REFG) recently partnered with Paper Lantern, LLC to create the nation’s largest mobile hemp CBD processing service. To view the full article, visit: http://nnw.fm/FxbM9.

Medical Cannabis Payment Solutions (OTC: REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.0393, up 0.77%, on 363,615 volume with 49 trades. The average volume for the last 60 days is 532,573 and the stock's 52-week low/high is $0.0161/$0.092.

Recent News

chart

Virtual Crypto Technologies Inc. (OTCQB: VRCP)

The QualityStocks Daily Newsletter would like to spotlight Virtual Crypto Technologies Inc. (VRCP).

NetworkNewsAudio announces the Audio Press Release (APR) titled "Acid Test for Cryptos and Blockchain Tech Increasingly about 'Spendability' and Usability," featuring Virtual Crypto Technologies Inc. (OTCQB: VRCP). To hear the NetworkNewsAudio version, visit http://nnw.fm/l9zId. To read the original editorial, visit http://nnw.fm/4H6qg.

Virtual Crypto Technologies Inc. (OTCQB: VRCP) is a developer of software and hardware for the purchase and sale of cryptocurrencies through ATMs, tablets, PCs and mobile devices. The company’s proprietary algorithmic technology trading platform, called NetoBit Trader, can instantaneously confirm the purchase or sale of Bitcoin, a process that typically can take between 10 minutes to 24 hours. All trades and exchanges are insured up to $3,000 per trade. The global cryptocurrency ATM market is predicted to surpass $285 million by 2025, yet, at present, only 30 percent of these machines allow two-way trades.

With NetoBit Trader, cryptocurrency holders enjoy immediate confirmation of Bitcoin and its crypto equivalents at the best crypto exchange rate at the point of transaction – providing a major breakthrough in the quest to bring cryptocurrencies to the mass market. Virtual Crypto’s cryptocurrency ATM, embedded with currency exchange transaction validation (CETV) in its hardware and software, accepts and dispenses cash and cryptocurrency in seconds.

Virtual Crypto’s NetoBit Trader and mobile retail point-of-sale platform incorporates advanced technologies tailored to the needs of primary market players, users, investors, and business owners. Virtual Crypto’s platform bridges the three main functions of the cryptocurrency sector – exchanges, wallets and payments – to the world of fiat exchanges, granting access to immediate cash exchanges between consumers and businesses worldwide.

NetoBit Trader’s over-the-counter, two-way transaction solution is available through one app, providing online cryptocurrency transactions at ecommerce and gaming portals. The app provides real-time cryptocurrency validation and exchange, easy buying and selling of Bitcoin with cash, enables traders to buy and trade crypto, and gamers to transfer cryptocurrency into cash after play. Crypto users can withdraw funds from their crypto accounts through a NetoBit cryptocurrency ATM or software-enabled tablet, and consumers can purchase retail with crypto from businesses that offer and use the NetoBit software.

The company’s newly redesigned corporate website, www.virtual-crypto.com, delivers a simple, clean design with enhanced functionality, features and navigation. Virtual Crypto’s new corporate website includes:

  • Downloadable NetoBit Trader app link and contact forms for more information
  • MarketWatch provides real-time tracking of the Bitcoin market, with other currencies to follow
  • Improved security utilizing https certificates to protect personal information and site integrity
  • Media room with downloadable product brochures, corporate presentations and other relevant content
  • Investor’s page provides transparency to investors with direct access to Virtual Crypto’s progress through press releases, SEC filings, senior management team bios, and stock performance charts
  • Social Media integration with buttons for LinkedIn, Twitter and Facebook jump to Virtual Crypto’s social media profiles, providing real-time updates from the online community

“Our primary objective is to make cryptocurrencies accessible to everyone, and that was the motivation for our redesign,” said Alon Dayan, Chief Executive Officer of Virtual Crypto. “The updated content provides real value for our customers, shareholders and employees, showcasing our products and services, in an intuitive, easy to navigate way.”

Virtual Crypto’s strategic vision of “Cryptocurrency Made Easy” allows crypto traders and users to overcome the complex hurdles currently hampering the cryptocurrency sphere.

Virtual Crypto Technologies Inc. (VRCP), closed the day's trading session at $0.103, off by 14.17%, on 31,711 volume with 13 trades. The average volume for the last 60 days is 34,934 and the stock's 52-week low/high is $0.0125/$0.38.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.